Q2 2017 Holdings
Filed 2017-08-14 | 144 holdings | $256.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $143.8M | 529,774 | 56.0% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $45.6M | 501,745 | 17.7% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $12.9M | 127,100 | 5.0% |
| Acadia Healthcare Company, Inc.(ACHC) | Common | 00404A109 | $11.4M | 231,200 | 4.4% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $9.2M | 114,966 | 3.6% |
| CytomX Therapeutics, Inc.(CTMX) | Common | 23284F105 | $8.2M | 530,092 | 3.2% |
| Cellectis S.A.(CLLS) | Sponsored ADR | 15117K103 | $8.0M | 310,250 | 3.1% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $6.6M | 1,466,368 | 2.6% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $3.3M | 639,370 | 1.3% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $2.0M | 203,935 | 0.8% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $1.6M | 75,000 | 0.6% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $1.3M | 90,000 | 0.5% |
| Allscripts Healthcare Solutions, Inc.(MDRX) | Common | 01988P108 | $604.0K | 47,300 | 0.2% |
| Celgene Corporation(CELG) | Common | 151020104 | $189.2K | 1,456,605 | 0.1% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $179.1K | 2,530,131 | 0.1% |
| Amgen Inc.(AMGN) | Common | 031162100 | $117.9K | 684,824 | 0.0% |
| Vertex Pharmaceuticals Incorporated(VRTX) | Common | 92532F100 | $102.8K | 798,053 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $94.5K | 714,362 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $94.4K | 1,473,295 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $92.2K | 187,666 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $91.4K | 750,905 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $87.3K | 693,275 | 0.0% |
| Allergan plc | Shares | G0177J108 | $75.5K | 310,610 | 0.0% |
| Mylan N.V. | Shares | N59465109 | $62.2K | 1,603,112 | 0.0% |
| Unitedhealth Group Inc.(UNH) | Common | 91324P102 | $57.0K | 307,476 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $56.0K | 1,152,520 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $51.5K | 580,326 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $48.4K | 278,960 | 0.0% |
| Jazz Pharmaceuticals plc(JAZZ) | Shares | G50871105 | $42.6K | 273,916 | 0.0% |
| Shire plc | Sponsored ADR | 82481R106 | $41.7K | 252,113 | 0.0% |
| Eli Lilly & Company(LLY) | Common | 532457108 | $40.6K | 493,100 | 0.0% |
| Teva Pharmaceutical Industries Ltd.(TEVA) | Sponsored ADR | 881624209 | $33.7K | 1,015,758 | 0.0% |
| Novartis AG(NVSN) | Sponsored ADR | 66987V109 | $33.3K | 398,662 | 0.0% |
| CVS Health Corporation(CVS) | Common | 126650100 | $33.1K | 411,891 | 0.0% |
| Humana Inc.(HUM) | Common | 444859102 | $30.0K | 124,781 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $27.2K | 810,087 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $25.9K | 562,467 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $24.3K | 139,120 | 0.0% |
| AmerisourceBergen Corporation(COR) | Common | 03073E105 | $24.1K | 254,887 | 0.0% |
| iShares Nasdaq Biotechnology ETF(IBB) | Nasdaq Biotech ETF | 464287556 | $23.6K | 75,970 | 0.0% |
| McKesson Corporation(MCK) | Common | 58155Q103 | $23.5K | 142,800 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $21.4K | 132,352 | 0.0% |
| AstraZeneca PLC(AZN) | Sponsored ADR | 046353108 | $18.8K | 550,600 | 0.0% |
| Puma Biotechnology, Inc.(PBYI) | Common | 74587V107 | $17.7K | 202,537 | 0.0% |
| Spdr S&P Biotech ETF(XBI) | S&P Biotech ETF | 78464A870 | $17.5K | 226,460 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $17.2K | 511,600 | 0.0% |
| GlaxoSmithKline plc | Shares | 37733W105 | $15.5K | 359,000 | 0.0% |
| Centene Corporation(CNC) | Common | 15135B101 | $15.4K | 192,600 | 0.0% |
| Omega Healthcare Investors, Inc.(OHI) | Common | 681936100 | $15.1K | 458,616 | 0.0% |
| Nevro Corp.(NVROEUR) | Common | 64157F103 | $14.5K | 194,621 | 0.0% |